Publications

Found 70 results
Filters: First Letter Of Last Name is M  [Clear All Filters]
2025
Rao S, Azuero-Dajud R, Lorman V, Landeo-Gutierrez J, Rhee KE, Ryu J, Kim C, Carmilani M, Gross RS, Mohandas S et al..  2025.  Ethnic and racial differences in children and young people with respiratory and neurological post-acute sequelae of SARS-CoV-2: an electronic health record-based cohort study from the RECOVER Initiative.. EClinicalMedicine. 80:103042.
Rao S, Azuero-Dajud R, Lorman V, Landeo-Gutierrez J, Rhee KE, Ryu J, Kim C, Carmilani M, Gross RS, Mohandas S et al..  2025.  Ethnic and racial differences in children and young people with respiratory and neurological post-acute sequelae of SARS-CoV-2: an electronic health record-based cohort study from the RECOVER Initiative.. EClinicalMedicine. 80:103042.
Rao S, Azuero-Dajud R, Lorman V, Landeo-Gutierrez J, Rhee KE, Ryu J, Kim C, Carmilani M, Gross RS, Mohandas S et al..  2025.  Ethnic and racial differences in children and young people with respiratory and neurological post-acute sequelae of SARS-CoV-2: an electronic health record-based cohort study from the RECOVER Initiative.. EClinicalMedicine. 80:103042.
Won THyung, Arifuzzaman M, Parkhurst CN, Miranda IC, Zhang B, Hu E, Kashyap S, Letourneau J, Jin W-B, Fu Y et al..  2025.  Host metabolism balances microbial regulation of bile acid signalling.. Nature. 638(8049):216-224.
Amisaki M, Zebboudj A, Yano H, Zhang SLinsey, Payne G, Chandra AKaya, Yu R, Guasp P, Sethna ZM, Ohmoto A et al..  2025.  IL-33-activated ILC2s induce tertiary lymphoid structures in pancreatic cancer.. Nature.
Amisaki M, Zebboudj A, Yano H, Zhang SLinsey, Payne G, Chandra AKaya, Yu R, Guasp P, Sethna ZM, Ohmoto A et al..  2025.  IL-33-activated ILC2s induce tertiary lymphoid structures in pancreatic cancer.. Nature.
Amisaki M, Zebboudj A, Yano H, Zhang SLinsey, Payne G, Chandra AKaya, Yu R, Guasp P, Sethna ZM, Ohmoto A et al..  2025.  IL-33-activated ILC2s induce tertiary lymphoid structures in pancreatic cancer.. Nature.
Amisaki M, Zebboudj A, Yano H, Zhang SLinsey, Payne G, Chandra AKaya, Yu R, Guasp P, Sethna ZM, Ohmoto A et al..  2025.  IL-33-activated ILC2s induce tertiary lymphoid structures in pancreatic cancer.. Nature.
Mayassi T, Li C, Segerstolpe Å, Brown EM, Weisberg R, Nakata T, Yano H, Herbst P, Artis D, Graham DB et al..  2025.  Publisher Correction: Spatially restricted immune and microbiota-driven adaptation of the gut.. Nature. 637(8044):E10.
2024
Zaiss DMW, Pearce EJ, Artis D, McKenzie ANJ, Klose CSN.  2024.  Cooperation of ILC2s and TH2 cells in the expulsion of intestinal helminth parasites.. Nat Rev Immunol. 24(4):294-302.
Liao Y, Gao IH, Kusakabe T, Lin W-Y, Grier A, Pan X, Morzhanaeva O, Shea TP, Yano H, Karo-Atar D et al..  2024.  Fungal symbiont transmitted by free-living mice promotes type 2 immunity.. Nature. 636(8043):697-704.
Troch KF, Jakob MO, Forster PM, Jarick KJ, Schreiber J, Preusser A, Guerra GM, Durek P, Tizian C, Sterczyk N et al..  2024.  Group 2 innate lymphoid cells are a non-redundant source of interleukin-5 required for development and function of murine B1 cells.. Nat Commun. 15(1):10566.
Mayassi T, Li C, Segerstolpe Å, Brown EM, Weisberg R, Nakata T, Yano H, Herbst P, Artis D, Graham DB et al..  2024.  Spatially restricted immune and microbiota-driven adaptation of the gut.. Nature. 636(8042):447-456.
Li Z, Ma R, Tang H, Guo J, Shah Z, Zhang J, Liu N, Cao S, Marcucci G, Artis D et al..  2024.  Therapeutic application of human type 2 innate lymphoid cells via induction of granzyme B-mediated tumor cell death.. Cell. 187(3):624-641.e23.
Li Z, Ma R, Tang H, Guo J, Shah Z, Zhang J, Liu N, Cao S, Marcucci G, Artis D et al..  2024.  Therapeutic application of human type 2 innate lymphoid cells via induction of granzyme B-mediated tumor cell death.. Cell. 187(3):624-641.e23.
Feng X, Andersson T, Gschwend J, Flüchter P, Berest I, Muff JL, Carchidi D, Lechner A, de Tenorio JC, Brander N et al..  2024.  Tuft cell IL-17RB restrains IL-25 bioavailability and reveals context-dependent ILC2 hypoproliferation.. bioRxiv.
2022
Göktuna SI, Canli O, Bollrath J, Fingerle AA, Horst D, Diamanti MA, Pallangyo C, Bennecke M, Nebelsiek T, Mankan AK et al..  2022.  IKKα Promotes Intestinal Tumorigenesis by Limiting Recruitment of M1-like Polarized Myeloid Cells.. Cell Rep. 38(9):110471.
Tsou AM, Yano H, Parkhurst CN, Mahlakõiv T, Chu C, Zhang W, He Z, Jarick KJ, Zhong C, Putzel GG et al..  2022.  Neuropeptide regulation of non-redundant ILC2 responses at barrier surfaces.. Nature. 611(7937):787-793.
Jarick KJ, Topczewska PM, Jakob MO, Yano H, Arifuzzaman M, Gao X, Boulekou S, Stokic-Trtica V, Leclère PS, Preußer A et al..  2022.  Non-redundant functions of group 2 innate lymphoid cells.. Nature. 611(7937):794-800.
2021
Chung H, Parkhurst CN, Magee EM, Phillips D, Habibi E, Chen F, Yeung BZ, Waldman J, Artis D, Regev A.  2021.  Joint single-cell measurements of nuclear proteins and RNA in vivo.. Nat Methods. 18(10):1204-1212.
2020
Flamar A-L, Klose CSN, Moeller JB, Mahlakõiv T, Bessman NJ, Zhang W, Moriyama S, Stokic-Trtica V, Rankin LC, Putzel GGarbès et al..  2020.  Interleukin-33 Induces the Enzyme Tryptophan Hydroxylase 1 to Promote Inflammatory Group 2 Innate Lymphoid Cell-Mediated Immunity.. Immunity.
Flamar A-L, Klose CSN, Moeller JB, Mahlakõiv T, Bessman NJ, Zhang W, Moriyama S, Stokic-Trtica V, Rankin LC, Putzel GGarbès et al..  2020.  Interleukin-33 Induces the Enzyme Tryptophan Hydroxylase 1 to Promote Inflammatory Group 2 Innate Lymphoid Cell-Mediated Immunity.. Immunity.
Flamar A-L, Klose CSN, Moeller JB, Mahlakõiv T, Bessman NJ, Zhang W, Moriyama S, Stokic-Trtica V, Rankin LC, Putzel GGarbès et al..  2020.  Interleukin-33 Induces the Enzyme Tryptophan Hydroxylase 1 to Promote Inflammatory Group 2 Innate Lymphoid Cell-Mediated Immunity.. Immunity.
Kabata H, Flamar A-L, Mahlakõiv T, Moriyama S, Rodewald H-R, Ziegler SF, Artis D.  2020.  Targeted deletion of the TSLP receptor reveals cellular mechanisms that promote type 2 airway inflammation.. Mucosal Immunol.
Kabata H, Flamar A-L, Mahlakõiv T, Moriyama S, Rodewald H-R, Ziegler SF, Artis D.  2020.  Targeted deletion of the TSLP receptor reveals cellular mechanisms that promote type 2 airway inflammation.. Mucosal Immunol.